Effect of Cantharidin, Cephalotaxine and Homoharringtonine on ”in vitro” Models of Hepatitis B Virus (HBV) and Bovine Viral Diarrhoea Virus (BVDV) Replication

Abstract

The effect as antiviral agents versus viral hepatitis B and C of three compounds purified from natural products commonly used as remedies in traditional Chinese medicine, cantharidin, cephalotaxine and homoharingtonine, was investigated. To assess the activity of these compounds against flavivirus, we used bovine viral diarrhoea virus (BVDV) as a surrogate for hepatitis C virus (HCV). Anti-BVDV activity was determined by reduction in BVDV-RNA production and protection of infected embryonic bovine trachea (EBTr) cells against the cytopathic effect of BVDV. The effect versus hepatitis B virus (HBV) was investigated by measuring HBsAg and HBV-DNA release from hepatoblastoma HepG2 2.2.15 cells infected with HBV. As positive control we used the standard anti-HBV and anti-HCV drugs, lamivudine and ribavirin, respectively. Up to 100 μM lamivudine and ribavirin did not induce cell toxicity, whereas they induced dose-dependent anti-HBV and anti-BVDV effects, respectively. In the same range, cantharidin, cephalotaxine and homoharringtonine induced toxicity in EBTr cells and had no protective effect against BVDV. In contrast, they were able to inhibit HBV production at concentrations 10- to 100-fold lower than those inducing cell toxicity, which suggests that they are useless for the treatment of infection by flaviviruses, but potentially useful in combined therapy against hepatitis B.

Abbreviations

BVDV:bovine viral diarrhoea virus

HBV:hepatitis B virus

HCV:hepatitis C virus

IFN:Interferon

Key words

BVDV - chemotherapy - flavivirus - HBV - HCV - liver - traditional Chinese medicine - cantharidin - cephalotaxine - homoharringtonine

References

• 1 Beasley R P, Hwang L Y. Overview on the epidemiology of hepatocellular carcinoma. In: Hollinger FB, Lemon SM and Margolis M, editors Viral hepatitis and liver disease. Baltimore; Williams and Willkins 1991: 532-5.
• 2 Liang T J, Rehermann B, Seeff L B, Hoofnagle J H. Pathogenesis, natural history, treatment, and prevention of hepatitis C.  Ann Intern Med. 2000;  132 296-305.
• 3 Tanikawa K. Pathogenesis and treatment of hepatitis C virus-related liver diseases.  Hepatobiliary Pancreat Dis Int. 2004;  3 17-20.
• 4 McHutchison J G, Gordon S C, Schiff E R, Shiffman M L, Lee W M, Rustgi V K. et al . Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.  N Engl J Med. 1998;  339 1485-92.
• 5 Romero M R, Efferth T, Serrano M A, Castano B, Macias R IR, Briz O. et al . Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an ”in vitro” replicative system.  Antiviral Res. 2005;  68 75-83.
• 6 Romero M R, Serrano M A, Vallejo M, Efferth T, Alvarez M, Marin J JG. Antiviral effect of artemisinin from Artemisia annua against a model member of the Flaviviridae family, the Bovine Viral Diarrhoea Virus (BVDV).  Planta Med. 2006;  72 1169-74.
• 7 Whaun J M, Brown N D. Treatment of chloroquine-resistant malaria with esters of cephalotaxine: homoharringtonine.  Ann Trop Med Parasitol. 1990;  84 229-37.
• 8 Visani G, Russo D, Ottaviani E, Tosi P, Damiani D, Michelutti A. et al . Effects of homoharringtonine alone and in combination with alpha interferon and cytosine arabinoside on ”in vitro” growth and induction of apoptosis in chronic myeloid leukemia and normal hematopoietic progenitors.  Leukemia. 1997;  11 624-8.
• 9 Efferth T, Davey M, Olbrich A, Rücker G, Gebhart E, Davey R. Activity of drugs from Traditional Chinese Medicine toward sensitive and MDR- or MRP1-overexpressing Multidrug-Resistant Human CCRF-CEM leukemia cells.  Blood Cells Mol Dis. 2002;  28 160-8.
• 10 Efferth T, Sauerbrey A, Halatsch M E, Ross D D, Gebhart E. Molecular modes of action of cephalotaxine and homoharringtonine from the coniferous tree Cephalotaxus hainanensis in human tumor cell lines.  Naunyn Schmiedebergs Arch Pharmacol. 2003;  367 56-67.
• 11 Zeisel M B, Baumert T F. Production of infectious hepatitis C virus in tissue culture: A breakthrough for basic and applied research.  J Hepatol. 2006;  44 436-9.
• 12 Buckwold V E, Beer B E, Donis R O. Bovine viral diarrhea virus as a surrogate model of hepatitis C virus for the evaluation of antiviral agents.  Antiviral Res. 2003;  60 1-15.
• 13 Fautz R, Husein B, Hechenberger C. Application of the Neutral Red assay (NR assay) to monolayer cultures of primary hepatocytes. Rapid colorimetric viability determination for the unscheduled DNA synthesis test (UDS).  Mutat Res. 1991;  235 173-9.
• 14 Kaneko S, Feinstone S M, Miller R H. Rapid and sensitive method for the detection of serum hepatitis B virus DNA using the polymerase chain reaction technique.  J Clin Microbiol. 1989;  27 1930-3.
• 15 Sells M A, Zelent A, Shvartsman M, Acs G. Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions.  J Virol. 1988;  62 2836-44.
• 16 Hanson D, Diven D G. Molluscum contagiosum.  Dermatol Online J. 2003;  9 2.
• 17 Baba Y, Hirukawa N, Sodeoka M. Optically active cantharidin analogues possessing selective inhibitory activity on Ser/Thr protein phosphatase 2B (calcineurin): implications for the binding mode.  Bioorg Med Chem. 2005;  13 5164-70.
• 18 Arroyo J D, Hahn W C. Involvement of PP2A in viral and cellular transformation.  Oncogene. 2005;  24 7746-55.
• 19 Duong F H, Christen V, Berke J M, Penna S H, Moradpour D, Heim M H. Upregulation of protein phosphatase 2Ac by hepatitis C virus modulates NS3 helicase activity through inhibition of protein arginine methyltransferase 1.  J Virol. 2005;  79 15 342-50.
• 20 Luo C Y, Tang J Y, Wang Y P. Homoharringtonine: a new treatment option for myeloid leukemia.  Hematology. 2004;  9 259-70.
• 21 Yinjun L, Jie J, Weilai X, Xiangming T. Homoharringtonine mediates myeloid cell apoptosis via upregulation of pro-apoptotic bax and inducing caspase-3-mediated cleavage of poly(ADP-ribose) polymerase (PARP).  Am J Hematol. 2004;  76 199-204.
• 22 Romero M R, Martinez-Diez M C, Larena M G, Macias R I, Dominguez M, Garcia-Monzon C. et al . Evidence for dual effects of DNA-reactive bile acid derivatives (Bamets) on hepatitis B virus life cycle in an in vitro replicative system.  Antivir Chem Chemother. 2002;  13 371-80.
• 23 Chouteau P, Le Seyec J, Saulier-Le Drean B, Cannie I, Brissot P, Lescoat G. et al . Inhibition of hepatitis B virus production associated with high levels of intracellular viral DNA intermediates in iron-depleted HepG2 2.2.15 cells.  J Hepatol. 2001;  34 108-13.
• 24 Zhou D C, Zittoun R, Marie J P. Homoharringtonine: an effective new natural product in cancer chemotherapy.  Bull Cancer. 1995;  82 987-95.